EquityZen Growth Technology Fund LLC - Series 1820
Raised
$505K
Investors
12
Min Invest
$10,005
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1820 is a Delaware-organized pooled investment vehicle filed by EquityZen Advisors LLC and Philip Haslett. The fund raised $505,000 from 12 investors under Regulation D exemptions 506(b) and 3(c), with a $10,000 minimum investment. This is part of EquityZen's platform, which has 150 related entities in EDGAR filings.
This private equity vehicle uses the common 506(b) exemption pattern with 3(c) exclusion, typical for pre-vetted investor pools. The $10,000 minimum represents an accessible entry point compared to typical institutional private equity minimums, consistent with EquityZen's platform model of providing retail-adjacent access to private company shares through serialized SPV structures.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
